JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Short Interest Up 100.0% in January

JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) was the target of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 200 shares, an increase of 100.0% from the December 31st total of 100 shares. Based on an average daily trading volume, of 500 shares, the days-to-cover ratio is currently 0.4 days.

JPMorgan Healthcare Leaders ETF Price Performance

Shares of JDOC traded down $0.29 on Friday, reaching $54.48. 966 shares of the stock traded hands, compared to its average volume of 643. The firm has a market cap of $8.17 million, a price-to-earnings ratio of 27.37 and a beta of 0.61. JPMorgan Healthcare Leaders ETF has a 12 month low of $50.54 and a 12 month high of $63.49. The stock’s 50-day moving average price is $53.50 and its 200-day moving average price is $57.81.

JPMorgan Healthcare Leaders ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 27th. Shareholders of record on Tuesday, December 24th were paid a $0.3276 dividend. The ex-dividend date of this dividend was Tuesday, December 24th.

Hedge Funds Weigh In On JPMorgan Healthcare Leaders ETF

An institutional investor recently bought a new position in JPMorgan Healthcare Leaders ETF stock. Krilogy Financial LLC acquired a new position in shares of JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,212 shares of the company’s stock, valued at approximately $517,000. Krilogy Financial LLC owned 6.81% of JPMorgan Healthcare Leaders ETF at the end of the most recent reporting period.

JPMorgan Healthcare Leaders ETF Company Profile

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation.